Australia's largest stock trading and investment forum Australia's #1 stock forum

Bayer AG, a great german company, page-6

First 6 Last

Share
Profile

Follow
mark2017

263 Posts.

21/05/17

23:23

Post #: 24824082
Share

Originally posted by mark2017 ↑

First quarter of 2017
Strong start to the year for Bayer

Group sales increase to €13.2 billion (Fx & portfolio adj.: +9.4%)
EBITDA before special items raised to €3.9 billion (+14.9%)
Growth momentum across all segments
Very good business development at Pharmaceuticals
Significant increase in sales and earnings at Covestro
Net income €2.1 billion (+37.9%)
Core earnings per share €2.62 (+11.5%)
Group outlook for 2017 raised, driven by Covestro performance
Economic situation of the Bayer Group

The Bayer Group got off to a very successful start to 2017. In the first quarter, sales increased by 9.4% on a currency- and portfolio-adjusted basis (Fx & portfolio adj.) to €13.2 billion and EBITDA before special items by a substantial 14.9% to €3.9 billion. At Pharmaceuticals, we once again benefited from the very good performance of our key growth products. Consumer Health, Crop Science and Animal Health also registered increases in sales and EBITDA before special items. Covestro posted substantial growth in sales and earnings.

http://www.quarterly-report-2017-q1.bayer.com/

Expand

Bayer Receives FDA Priority Review For Investigational Anti-Cancer Compound Copanlisib

http://www.investor.bayer.de/en/nc/...estigational-anti-cancer-compound-copanlisib/
Upvote

Reply

Top Stories

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

There are more pages in this discussion • 9 more messages in this thread...

First 6 Last